{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T08:09:49Z","timestamp":1776499789683,"version":"3.51.2"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Danone Nutricia","award":["Danone Nutricia"],"award-info":[{"award-number":["Danone Nutricia"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Inborn errors of metabolism (IEM) are inherited disorders affecting metabolism which can result in intellectual disability, cognitive impairment or death if left untreated. Nutritional management plays a major role in ensuring adequate growth, nutritional status and development, reducing levels of toxic metabolites, preventing deficiencies and avoiding catabolism in infants with IEM. The aim of this consensus is to provide recommendations for nutritional management of metabolic diseases in neonates and infants in Saudi Arabia, where a high frequency of IEM has been reported.<\/jats:p>\n                  <jats:p>Consensus generation was performed using the Delphi method. Six metabolic dietitians from five hospitals across KSA formed the expert panel. Two face-to face meetings and one virtual meeting were conducted to generate consensus statements. Voting was conducted anonymously on SurveyMonkey to determine the level of agreement with each recommendation.<\/jats:p>\n                  <jats:p>The expert panel reached consensus on 105 recommendations relating to the nutritional management of metabolic disorders, focusing on PA, MMA, GA1, PKU, MSUD, VLCAD, and HCU.<\/jats:p>\n                  <jats:p>These recommendations will facilitate more consistent management of metabolic patients across Saudi Arabia and strive to highlight ongoing challenges faced by dietitians, patients, and caregivers. Future work should focus on outcomes associated with dietary management strategies in Saudi Arabia.<\/jats:p>","DOI":"10.1186\/s13023-025-03949-0","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T20:54:06Z","timestamp":1763412846000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nutritional management of metabolic disorders in neonates and infants in Saudi Arabia: consensus recommendations"],"prefix":"10.1186","volume":"20","author":[{"given":"Bedour","family":"Handoom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman","family":"Alohali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hifa","family":"Elsagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Alohali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naif","family":"Alhamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wafaa","family":"Alabyad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"issue":"11","key":"3949_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1136\/adc.2005.091637","volume":"91","author":"S Sanderson","year":"2006","unstructured":"Sanderson S, Green A, Preece MA, Burton H. The incidence of inherited metabolic disorders in the West midlands, UK. Arch Dis Child. 2006;91(11):896\u20139.","journal-title":"Arch Dis Child"},{"issue":"2","key":"3949_CR2","doi-asserted-by":"publisher","first-page":"021102","DOI":"10.7189\/jogh.08.021102","volume":"8","author":"D Waters","year":"2018","unstructured":"Waters D, Adeloye D, Woolham D, Wastnedge E, Patel S, Rudan I. Global birth prevalence and mortality from inborn errors of metabolism: a systematic analysis of the evidence. J Glob Health. 2018;8(2):021102.","journal-title":"J Glob Health"},{"issue":"5","key":"3949_CR3","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/jimd.12129","volume":"42","author":"HA Haijes","year":"2019","unstructured":"Haijes HA, Jans JJM, Tas SY, Verhoeven-Duif NM, van Hasselt PM. Pathophysiology of propionic and methylmalonic acidemias. Part 1: complications. J Inherit Metab Dis. 2019;42(5):730\u201344.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"3949_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/ajmg.c.30088","volume":"142C","author":"GL Hedlund","year":"2006","unstructured":"Hedlund GL, Longo N, Pasquali M. Glutaric acidemia type 1. Am J Med Genet C Semin Med Genet. 2006;142\u00a0C(2):86\u201394.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"4","key":"3949_CR5","first-page":"304","volume":"4","author":"N Al Hafid","year":"2015","unstructured":"Al Hafid N, Christodoulou J. Phenylketonuria: a review of current and future treatments. Transl Pediatr. 2015;4(4):304\u201317.","journal-title":"Transl Pediatr"},{"key":"3949_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/TACG.S125962","volume":"10","author":"PR Blackburn","year":"2017","unstructured":"Blackburn PR, Gass JM, Vairo FPE, Farnham KM, Atwal HK, Macklin S, et al. Maple syrup urine disease: mechanisms and management. Appl Clin Genet. 2017;10:57\u201366.","journal-title":"Appl Clin Genet"},{"issue":"4","key":"3949_CR7","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ymgme.2014.01.009","volume":"111","author":"JL Merritt","year":"2014","unstructured":"Merritt JL 2nd, Vedal S, Abdenur JE, Au SM, Barshop BA, Feuchtbaum L, et al. Infants suspected to have very-long chain acyl-CoA dehydrogenase deficiency from newborn screening. Mol Genet Metab. 2014;111(4):484\u201392.","journal-title":"Mol Genet Metab"},{"key":"3949_CR8","unstructured":"Gerrard A, Dawson C. Homocystinuria diagnosis and management: it is not all classical. J Clin Pathol. 2022;jclinpath-2021-208029."},{"issue":"1","key":"3949_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13023-018-0987-z","volume":"14","author":"T Almasi","year":"2019","unstructured":"Almasi T, Guey LT, Lukacs C, Csetneki K, Voko Z, Zelei T. Systematic literature review and meta-analysis on the epidemiology of propionic acidemia. Orphanet J Rare Dis. 2019;14(1):40.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3949_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13023-019-1063-z","volume":"14","author":"T Almasi","year":"2019","unstructured":"Almasi T, Guey LT, Lukacs C, Csetneki K, Voko Z, Zelei T. Systematic literature review and meta-analysis on the epidemiology of methylmalonic acidemia (MMA) with a focus on MMA caused by methylmalonyl-CoA mutase (mut) deficiency. Orphanet J Rare Dis. 2019;14(1):84.","journal-title":"Orphanet J Rare Dis"},{"key":"3949_CR11","first-page":"106","volume":"15","author":"KA Chapman","year":"2018","unstructured":"Chapman KA, Gramer G, Viall S, Summar ML. Incidence of maple syrup urine disease, propionic acidemia, and methylmalonic aciduria from newborn screening data. Mol Genet Metab Rep. 2018;15:106\u20139.","journal-title":"Mol Genet Metab Rep"},{"issue":"2","key":"3949_CR12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ajhg.2020.06.006","volume":"107","author":"A Hillert","year":"2020","unstructured":"Hillert A, Anikster Y, Belanger-Quintana A, Burlina A, Burton BK, Carducci C, et al. The genetic landscape and epidemiology of phenylketonuria. Am J Hum Genet. 2020;107(2):234\u201350.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"3949_CR13","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1023\/B:BOLI.0000045769.96657.af","volume":"27","author":"M Lindner","year":"2004","unstructured":"Lindner M, Kolker S, Schulze A, Christensen E, Greenberg CR, Hoffmann GF. Neonatal screening for glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 2004;27(6):851\u20139.","journal-title":"J Inherit Metab Dis"},{"key":"3949_CR14","doi-asserted-by":"publisher","first-page":"648493","DOI":"10.3389\/fgene.2021.648493","volume":"12","author":"ZI Remec","year":"2021","unstructured":"Remec ZI, Groselj U, Drole Torkar A, Zerjav Tansek M, Cuk V, Perko D, et al. Very Long-Chain Acyl-CoA dehydrogenase deficiency: high incidence of detected patients with expanded newborn screening program. Front Genet. 2021;12:648493.","journal-title":"Front Genet"},{"key":"3949_CR15","doi-asserted-by":"crossref","unstructured":"Al-Sadeq DW, Nasrallah GK. The spectrum of mutations of homocystinuria in the MENA region. Genes (Basel). 2020;11(3).","DOI":"10.3390\/genes11030330"},{"issue":"4","key":"3949_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4103\/0256-4947.65254","volume":"30","author":"H Moammar","year":"2010","unstructured":"Moammar H, Cheriyan G, Mathew R, Al-Sannaa N. Incidence and patterns of inborn errors of metabolism in the Eastern Province of Saudi arabia, 1983\u20132008. Ann Saudi Med. 2010;30(4):271\u20137.","journal-title":"Ann Saudi Med"},{"issue":"12","key":"3949_CR17","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1177\/00099228231163511","volume":"62","author":"M Al Qurashi","year":"2023","unstructured":"Al Qurashi M, Alahmadi S, Mustafa A, Aga SS, Al Hindi M, Ahmed A, et al. Incidence of inborn errors of metabolism in newborn infants: five years\u2019 Single-Center experience, jeddah, Saudi Arabia. Clin Pediatr (Phila). 2023;62(12):1523\u201330.","journal-title":"Clin Pediatr (Phila)"},{"issue":"6","key":"3949_CR18","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/jpc.13469","volume":"53","author":"M Alfadhel","year":"2017","unstructured":"Alfadhel M, Al Othaim A, Al Saif S, Al Mutairi F, Alsayed M, Rahbeeni Z, et al. Expanded newborn screening program in Saudi arabia: incidence of screened disorders. J Paediatr Child Health. 2017;53(6):585\u201391.","journal-title":"J Paediatr Child Health"},{"issue":"1","key":"3949_CR19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13023-016-0510-3","volume":"11","author":"M Alfadhel","year":"2016","unstructured":"Alfadhel M, Benmeakel M, Hossain MA, Al Mutairi F, Al Othaim A, Alfares AA, et al. Thirteen year retrospective review of the spectrum of inborn errors of metabolism presenting in a tertiary center in Saudi Arabia. Orphanet J Rare Dis. 2016;11(1):126.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"3949_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0146-0005(99)80050-0","volume":"23","author":"MS Rashed","year":"1999","unstructured":"Rashed MS, Rahbeeni Z, Ozand PT. Application of electrospray tandem mass spectrometry to neonatal screening. Semin Perinatol. 1999;23(2):183\u201393.","journal-title":"Semin Perinatol"},{"issue":"4","key":"3949_CR21","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1177\/0884533615586201","volume":"30","author":"SW Boyer","year":"2015","unstructured":"Boyer SW, Barclay LJ, Burrage LC. Inherited metabolic disorders: aspects of chronic nutrition management. Nutr Clin Pract. 2015;30(4):502\u201310.","journal-title":"Nutr Clin Pract"},{"issue":"Suppl 3","key":"3949_CR22","first-page":"198","volume":"34","author":"B Wilcken","year":"2003","unstructured":"Wilcken B. An introduction to nutritional treatment in inborn errors of metabolism\u2013different disorders, different approaches. Southeast Asian J Trop Med Public Health. 2003;34(Suppl 3):198\u2013201.","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"1\u20132","key":"3949_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ymgme.2012.07.005","volume":"107","author":"KM Camp","year":"2012","unstructured":"Camp KM, Lloyd-Puryear MA, Huntington KL. Nutritional treatment for inborn errors of metabolism: indications, regulations, and availability of medical foods and dietary supplements using phenylketonuria as an example. Mol Genet Metab. 2012;107(1\u20132):3\u20139.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"3949_CR24","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ymgme.2012.01.014","volume":"105","author":"SL Weber","year":"2012","unstructured":"Weber SL, Segal S, Packman W. Inborn errors of metabolism: psychosocial challenges and proposed family systems model of intervention. Mol Genet Metab. 2012;105(4):537\u201341.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"3949_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s13023-024-03315-6","volume":"19","author":"T Harings","year":"2024","unstructured":"Harings T, Neininger MP, Eisenhofer S, Thiele AG, Kiess W, Bertsche A, et al. The impact of a child\u2019s inborn error of metabolism: the parents\u2019 perspectives on restrictions, discrimination, family planning, and emergency management. Orphanet J Rare Dis. 2024;19(1):313.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"3949_CR26","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ymgme.2019.02.007","volume":"126","author":"E Jurecki","year":"2019","unstructured":"Jurecki E, Ueda K, Frazier D, Rohr F, Thompson A, Hussa C, et al. Nutrition management guideline for propionic acidemia: an evidence- and consensus-based approach. Mol Genet Metab. 2019;126(4):341\u201354.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"3949_CR27","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/jimd.12566","volume":"46","author":"N Boy","year":"2023","unstructured":"Boy N, Muhlhausen C, Maier EM, Ballhausen D, Baumgartner MR, Beblo S, et al. Recommendations for diagnosing and managing individuals with glutaric aciduria type 1: third revision. J Inherit Metab Dis. 2023;46(3):482\u2013519.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"3949_CR28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ymgme.2016.04.008","volume":"118","author":"RH Singh","year":"2016","unstructured":"Singh RH, Cunningham AC, Mofidi S, Douglas TD, Frazier DM, Hook DG, et al. Updated, web-based nutrition management guideline for PKU: an evidence and consensus based approach. Mol Genet Metab. 2016;118(2):72\u201383.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"3949_CR29","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ymgme.2014.05.006","volume":"112","author":"DM Frazier","year":"2014","unstructured":"Frazier DM, Allgeier C, Homer C, Marriage BJ, Ogata B, Rohr F, et al. Nutrition management guideline for maple syrup urine disease: an evidence- and consensus-based approach. Mol Genet Metab. 2014;112(3):210\u20137.","journal-title":"Mol Genet Metab"},{"issue":"1\u20132","key":"3949_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ymgme.2020.10.001","volume":"131","author":"SC Van Calcar","year":"2020","unstructured":"Van Calcar SC, Sowa M, Rohr F, Beazer J, Setlock T, Weihe TU, et al. Nutrition management guideline for very-long chain acyl-CoA dehydrogenase deficiency (VLCAD): an evidence- and consensus-based approach. Mol Genet Metab. 2020;131(1\u20132):23\u201337.","journal-title":"Mol Genet Metab"},{"key":"3949_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-030-67727-5_1","volume-title":"Physician\u2019s guide to the diagnosis, treatment, and Follow-Up of inherited metabolic diseases","author":"R Fingerhut","year":"2022","unstructured":"Fingerhut R, Fletcher J, Ranieri E. Newborn screening for inborn errors of metabolism. In: Blau N, Dionisi Vici C, Ferreira CR, Vianey-Saban C, van Karnebeek CDM, editors. Physician\u2019s guide to the diagnosis, treatment, and Follow-Up of inherited metabolic diseases. Cham: Springer International Publishing; 2022. pp. 3\u201316."},{"issue":"3","key":"3949_CR32","doi-asserted-by":"publisher","first-page":"e139791","DOI":"10.5812\/jjcdc-139791","volume":"13","author":"S Shirdelzade","year":"2024","unstructured":"Shirdelzade S, Ramezani M, Eshraghi P, Heydari A. Care needs of children with inborn errors of metabolism and their parents: an integrative review. Jundishapur J Chronic Dis Care. 2024;13(3):e139791.","journal-title":"Jundishapur J Chronic Dis Care"},{"key":"3949_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1750-1172-8-37","volume":"8","author":"S Demirdas","year":"2013","unstructured":"Demirdas S, van Kessel IN, Korndewal MJ, Hollak CE, Meutgeert H, Klaren A, et al. Clinical pathways for inborn errors of metabolism: warranted and feasible. Orphanet J Rare Dis. 2013;8:37.","journal-title":"Orphanet J Rare Dis"},{"key":"3949_CR34","unstructured":"Metabolic Dietitians National Centre for Inherited Metabolic Disorders. Maple Syrup Urine Disease Handbook 2017 [Available from: https:\/\/metabolic.ie\/wp-content\/uploads\/2015\/05\/MSUD-Handbook.pdf"},{"key":"3949_CR35","doi-asserted-by":"crossref","unstructured":"Dixon M. Emergency regimens for inherited metabolic disorders. Clin Pediatr Dietetics. 2020:673\u201380.","DOI":"10.1002\/9781119467205.ch31"},{"key":"3949_CR36","unstructured":"GMDI. MSUD Nutrition Management Guidelines. 2024 [Available from: https:\/\/managementguidelines.net\/guidelines.php\/147\/MSUD%20Nutrition%20Guidelines\/Version%202.0"},{"key":"3949_CR37","unstructured":"GMDI. PROP Nutrition Management Guidelines 2017 [Available from: https:\/\/managementguidelines.net\/guidelines.php\/104\/PROP%20Nutrition%20Guidelines\/Version%201.2"},{"key":"3949_CR38","unstructured":"GMDI. VLCAD Nutrition Management Guidelines. 2022 [Available from: https:\/\/managementguidelines.net\/guidelines.php\/146\/VLCAD%20Nutrition%20Guidelines\/Version%201.4"},{"key":"3949_CR39","unstructured":"GMDI. PKU Nutrition Management Guidelines. 2022 [Available from: https:\/\/managementguidelines.net\/guidelines.php\/136\/PKU%20Nutrition%20Guidelines\/Version%202.5"},{"issue":"7","key":"3949_CR40","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s12098-011-0422-0","volume":"78","author":"N Gupta","year":"2011","unstructured":"Gupta N, Kabra M. Acute management of sick infants with suspected inborn errors of metabolism. Indian J Pediatr. 2011;78(7):854\u20139.","journal-title":"Indian J Pediatr"},{"key":"3949_CR41","first-page":"100757","volume":"27","author":"A Mobarak","year":"2021","unstructured":"Mobarak A, Stockler S, Salvarinova R, Van Karnebeek C, Horvath G. Long term follow-up of the dietary intake in propionic acidemia. Mol Genet Metab Rep. 2021;27:100757.","journal-title":"Mol Genet Metab Rep"},{"issue":"3","key":"3949_CR42","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/BF01953939","volume":"155","author":"SB van der Meer","year":"1996","unstructured":"van der Meer SB, Poggi F, Spada M, Bonnefont JP, Ogier H, Hubert P, et al. Clinical outcome and long-term management of 17 patients with propionic acidaemia. Eur J Pediatr. 1996;155(3):205\u201310.","journal-title":"Eur J Pediatr"},{"issue":"4","key":"3949_CR43","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10545-005-0457-3","volume":"28","author":"G Huner","year":"2005","unstructured":"Huner G, Baykal T, Demir F, Demirkol M. Breastfeeding experience in inborn errors of metabolism other than phenylketonuria. J Inherit Metab Dis. 2005;28(4):457\u201365.","journal-title":"J Inherit Metab Dis"},{"key":"3949_CR44","volume-title":"Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids","author":"Institute of Medicine","year":"2005","unstructured":"Institute of Medicine. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington, DC: National Academies; 2005."},{"key":"3949_CR45","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13023-014-0130-8","volume":"9","author":"MR Baumgartner","year":"2014","unstructured":"Baumgartner MR, Horster F, Dionisi-Vici C, Haliloglu G, Karall D, Chapman KA, et al. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis. 2014;9:130.","journal-title":"Orphanet J Rare Dis"},{"key":"3949_CR46","unstructured":"Abbott. Food List for Methylmalonic Acidemia. 2020."},{"issue":"1","key":"3949_CR47","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13023-018-0963-7","volume":"13","author":"J Haberle","year":"2018","unstructured":"Haberle J, Chakrapani A, Ah Mew N, Longo N. Hyperammonaemia in classic organic acidaemias: a review of the literature and two case histories. Orphanet J Rare Dis. 2018;13(1):219.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"3949_CR48","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.pedn.2008.02.004","volume":"23","author":"L Van Gosen","year":"2008","unstructured":"Van Gosen L. Organic acidemias: a methylmalonic and propionic focus. J Pediatr Nurs. 2008;23(3):225\u201333.","journal-title":"J Pediatr Nurs"},{"key":"3949_CR49","unstructured":"Abbott A. Guide for Families Who Have a Child With Propionic Acidemia. 2020."},{"issue":"50","key":"3949_CR50","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.1016\/j.vaccine.2012.10.012","volume":"30","author":"F Menni","year":"2012","unstructured":"Menni F, Chiarelli G, Sabatini C, Principi N, Esposito S. Vaccination in children with inborn errors of metabolism. Vaccine. 2012;30(50):7161\u20134.","journal-title":"Vaccine"},{"issue":"3","key":"3949_CR51","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10545-012-9517-7","volume":"36","author":"N Boy","year":"2013","unstructured":"Boy N, Haege G, Heringer J, Assmann B, M\u00fchlhausen C, Ensenauer R, et al. Low lysine diet in glutaric aciduria type I\u2013effect on anthropometric and biochemical follow-up parameters. J Inherit Metab Dis. 2013;36(3):525\u201333.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"3949_CR52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41436-020-00971-4","volume":"23","author":"N Boy","year":"2021","unstructured":"Boy N, Mengler K, Heringer-Seifert J, Hoffmann GF, Garbade SF, Kolker S. Impact of newborn screening and quality of therapy on the neurological outcome in glutaric aciduria type 1: a meta-analysis. Genet Med. 2021;23(1):13\u201321.","journal-title":"Genet Med"},{"issue":"3","key":"3949_CR53","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ymgme.2020.09.007","volume":"131","author":"KA Strauss","year":"2020","unstructured":"Strauss KA, Williams KB, Carson VJ, Poskitt L, Bowser LE, Young M, et al. Glutaric acidemia type 1: treatment and outcome of 168 patients over three decades. Mol Genet Metab. 2020;131(3):325\u201340.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"3949_CR54","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1023\/B:BOLI.0000045775.03183.48","volume":"27","author":"E M\u00fcller","year":"2004","unstructured":"M\u00fcller E, K\u00f6lker S. Reduction of lysine intake while avoiding malnutrition\u2013major goals and major problems in dietary treatment of glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 2004;27(6):903\u201310.","journal-title":"J Inherit Metab Dis"},{"key":"3949_CR55","unstructured":"Abbott. Food List for Glutaric Aciduria Type I. 2020."},{"key":"3949_CR56","unstructured":"Metabolic Dietitians National Centre for Inherited Metabolic Disorders. Glutaric Aciduria Type 1 Handbook 2019 [Available from: https:\/\/metabolic.ie\/wp-content\/uploads\/2015\/06\/GA-1-Handbook.pdf"},{"key":"3949_CR57","doi-asserted-by":"crossref","unstructured":"Bernstein L, Coughlin CR, Drumm M, Yannicelli S, Rohr F. Inconsistencies in the nutrition management of glutaric aciduria type 1: an international survey. Nutrients. 2020;12(10).","DOI":"10.3390\/nu12103162"},{"key":"3949_CR58","doi-asserted-by":"publisher","first-page":"704984","DOI":"10.3389\/fnut.2021.704984","volume":"8","author":"Q Li","year":"2021","unstructured":"Li Q, Yang C, Feng L, Zhao Y, Su Y, Liu H, et al. Glutaric acidemia, pathogenesis and nutritional therapy. Front Nutr. 2021;8:704984.","journal-title":"Front Nutr"},{"key":"3949_CR59","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-3-319-14621-8_19","volume-title":"Nutrition management of interited metabolic diseases","author":"L Bernstein","year":"2015","unstructured":"Bernstein L. Nutrition management of glutaric acidemia type 1. In: Bernstein L, Rohr F, Helm JR, editors. Nutrition management of interited metabolic diseases. Switzerland: Springer Cham; 2015. pp. 211\u201320."},{"key":"3949_CR60","doi-asserted-by":"crossref","unstructured":"Yannicelli S, Rohr F, Warman ML. Nutrition support for glutaric acidemia type I. J Am Diet Assoc. 1994;94(2):183-8,91; quiz 9\u201390.","DOI":"10.1016\/0002-8223(94)90245-3"},{"issue":"6","key":"3949_CR61","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1365-277X.2012.01269.x","volume":"25","author":"H Gokmen-Ozel","year":"2012","unstructured":"Gokmen-Ozel H, MacDonald A, Daly A, Ashmore C, Preece MA, Hendriksz C, et al. Dietary practices in glutaric aciduria type 1 over 16 years. J Hum Nutr Diet. 2012;25(6):514\u20139.","journal-title":"J Hum Nutr Diet"},{"issue":"3","key":"3949_CR62","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1055\/s-0043-1771353","volume":"22","author":"VK Gowda","year":"2024","unstructured":"Gowda VK, Shamnur A, Srinivasan VM, Vamyanmane DK. A rare treatable complication of neuroregression in glutaric aciduria type 1 management: vitamin B12 deficiency. J Pediatr Neurol. 2024;22(3):230\u20133.","journal-title":"J Pediatr Neurol"},{"issue":"1","key":"3949_CR63","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10545-016-9999-9","volume":"40","author":"N Boy","year":"2017","unstructured":"Boy N, Muhlhausen C, Maier EM, Heringer J, Assmann B, Burgard P, et al. Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision. J Inherit Metab Dis. 2017;40(1):75\u2013101.","journal-title":"J Inherit Metab Dis"},{"issue":"7","key":"3949_CR64","first-page":"CD001304","volume":"7","author":"E Jameson","year":"2020","unstructured":"Jameson E, Remmington T. Dietary interventions for phenylketonuria. Cochrane Database Syst Rev. 2020;7(7):CD001304.","journal-title":"Cochrane Database Syst Rev"},{"key":"3949_CR65","doi-asserted-by":"crossref","unstructured":"Ilgaz F, Marsaux C, Pinto A, Singh R, Rohde C, Karabulut E et al. Protein substitute requirements of patients with phenylketonuria on BH4 treatment: A systematic review and Meta-Analysis. Nutrients. 2021;13(3).","DOI":"10.3390\/nu13031040"},{"issue":"1","key":"3949_CR66","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13023-020-01391-y","volume":"15","author":"A MacDonald","year":"2020","unstructured":"MacDonald A, van Wegberg AMJ, Ahring K, Beblo S, Belanger-Quintana A, Burlina A, et al. PKU dietary handbook to accompany PKU guidelines. Orphanet J Rare Dis. 2020;15(1):171.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3949_CR67","doi-asserted-by":"publisher","first-page":"e002066","DOI":"10.1136\/bmjpo-2023-002066","volume":"7","author":"J Kalvala","year":"2023","unstructured":"Kalvala J, Chong L, Chadborn N, Ojha S. Breast feeding in infants diagnosed with phenylketonuria (PKU): a scoping review. BMJ Paediatr Open. 2023;7(1):e002066.","journal-title":"BMJ Paediatr Open"},{"issue":"2","key":"3949_CR68","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ymgme.2014.02.013","volume":"112","author":"KM Camp","year":"2014","unstructured":"Camp KM, Parisi MA, Acosta PB, Berry GT, Bilder DA, Blau N, et al. Phenylketonuria scientific review conference: state of the science and future research needs. Mol Genet Metab. 2014;112(2):87\u2013122.","journal-title":"Mol Genet Metab"},{"key":"3949_CR69","doi-asserted-by":"crossref","unstructured":"Pinto A, Daly A, Rocha JC, Ashmore C, Evans S, Jackson R et al. Preliminary Data on Free Use of Fruits and Vegetables Containing Phenylalanine 76\u2013100\u00a0mg\/100\u00a0g of Food in 16 Children with Phenylketonuria: 6 Months Follow-Up. Nutrients. 2023;15(13).","DOI":"10.3390\/nu15133046"},{"key":"3949_CR70","doi-asserted-by":"crossref","unstructured":"Pinto A, Daly A, Rocha JC, Ashmore C, Evans S, Jackson R et al. Impact of fruit and vegetable protein vs. Milk protein on metabolic control of children with phenylketonuria: A randomized crossover controlled trial. Nutrients. 2022;14(20).","DOI":"10.3390\/nu14204268"},{"issue":"1","key":"3949_CR71","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13023-017-0685-2","volume":"12","author":"AMJ van Wegberg","year":"2017","unstructured":"van Wegberg AMJ, MacDonald A, Ahring K, Belanger-Quintana A, Blau N, Bosch AM, et al. The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis. 2017;12(1):162.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"3949_CR72","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1023\/A:1025150901439","volume":"26","author":"A MacDonald","year":"2003","unstructured":"MacDonald A, Rylance G, Davies P, Asplin D, Hall SK, Booth IW. Free use of fruits and vegetables in phenylketonuria. J Inherit Metab Dis. 2003;26(4):327\u201338.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"3949_CR73","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3945\/jn.116.240218","volume":"147","author":"A Turki","year":"2017","unstructured":"Turki A, Ueda K, Cheng B, Giezen A, Salvarinova R, Stockler-Ipsiroglu S, et al. The indicator amino acid oxidation method with the use of l-[1-13\u00a0C]Leucine suggests a higher than currently recommended protein requirement in children with phenylketonuria. J Nutr. 2017;147(2):211\u20137.","journal-title":"J Nutr"},{"key":"3949_CR74","doi-asserted-by":"crossref","unstructured":"Evans S, Adam S, Adams S, Allen H, Ashmore C, Bailey S et al. Uniformity of food protein interpretation amongst dietitians for patients with phenylketonuria (PKU): 2020 UK National consensus statements. Nutrients. 2020;12(8).","DOI":"10.3390\/nu12082205"},{"issue":"9","key":"3949_CR75","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S2213-8587(16)30320-5","volume":"5","author":"FJ van Spronsen","year":"2017","unstructured":"van Spronsen FJ, van Wegberg AM, Ahring K, Belanger-Quintana A, Blau N, Bosch AM, et al. Key European guidelines for the diagnosis and management of patients with phenylketonuria. Lancet Diabetes Endocrinol. 2017;5(9):743\u201356.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"3949_CR76","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1038\/ejcn.2017.38","volume":"71","author":"A Pinto","year":"2017","unstructured":"Pinto A, Almeida MF, Ramos PC, Rocha S, Guimas A, Ribeiro R, et al. Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source. Eur J Clin Nutr. 2017;71(10):1230\u20134.","journal-title":"Eur J Clin Nutr"},{"key":"3949_CR77","doi-asserted-by":"crossref","unstructured":"Pinto A, Almeida MF, MacDonald A, Ramos PC, Rocha S, Guimas A et al. Over restriction of dietary protein allowance: the importance of ongoing reassessment of natural protein tolerance in phenylketonuria. Nutrients. 2019;11(5).","DOI":"10.3390\/nu11050995"},{"key":"3949_CR78","doi-asserted-by":"crossref","unstructured":"Calcar S. Nutrition management of maple syrup urine disease. Nutr Manage. 2015:173\u201383.","DOI":"10.1007\/978-3-319-14621-8_16"},{"issue":"11","key":"3949_CR79","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1007\/s00134-001-1124-2","volume":"27","author":"P Jouvet","year":"2001","unstructured":"Jouvet P, Jugie M, Rabier D, Desgres J, Hubert P, Saudubray JM, et al. Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease. Intensive Care Med. 2001;27(11):1798\u2013806.","journal-title":"Intensive Care Med"},{"issue":"1","key":"3949_CR80","first-page":"58","volume":"113","author":"RG Westall","year":"1967","unstructured":"Westall RG. Dietary treatment of maple syrup urine disease. Am J Dis Child. 1967;113(1):58\u20139.","journal-title":"Am J Dis Child"},{"issue":"4","key":"3949_CR81","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ymgme.2009.12.007","volume":"99","author":"KA Strauss","year":"2010","unstructured":"Strauss KA, Wardley B, Robinson D, Hendrickson C, Rider NL, Puffenberger EG, et al. Classical maple syrup urine disease and brain development: principles of management and formula design. Mol Genet Metab. 2010;99(4):333\u201345.","journal-title":"Mol Genet Metab"},{"key":"3949_CR82","doi-asserted-by":"crossref","unstructured":"Alrige M, Banjar H, Shuaib T, Ahmed A, Gharbawi R. Knowledge-Based dietary intake recommendations of nutrients for pediatric patients with maple syrup urine disease. Healthc (Basel). 2023;11(3).","DOI":"10.3390\/healthcare11030301"},{"issue":"2","key":"3949_CR83","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/ajcn\/36.2.359","volume":"36","author":"I Townsend","year":"1982","unstructured":"Townsend I, Kerr DS. Total parenteral nutrition therapy of toxic maple syrup urine disease. Am J Clin Nutr. 1982;36(2):359\u201365.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"3949_CR84","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1203\/01.pdr.0000190571.60385.34","volume":"59","author":"B Hoffmann","year":"2006","unstructured":"Hoffmann B, Helbling C, Schadewaldt P, Wendel U. Impact of longitudinal plasma leucine levels on the intellectual outcome in patients with classic MSUD. Pediatr Res. 2006;59(1):17\u201320.","journal-title":"Pediatr Res"},{"issue":"1","key":"3949_CR85","first-page":"95","volume":"58","author":"A Kowalik","year":"2007","unstructured":"Kowalik A, Narojek L, Sykut-Cegielska J. [Compliance of the diet restricted with leucine, isoleucine and valine in maple syrup urine disease (MSUD) children]. Rocz Panstw Zakl Hig. 2007;58(1):95\u2013101.","journal-title":"Rocz Panstw Zakl Hig"},{"key":"3949_CR86","unstructured":"Hassan SA, Gupta V. Maple Syrup Urine Disease2024."},{"issue":"1","key":"3949_CR87","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1515\/jpem-2018-0485","volume":"32","author":"F Porta","year":"2019","unstructured":"Porta F, Busso M, Giorda S, Spada M. Columbus\u2019 egg: a practical approach to nutritional management in maple syrup urine disease. J Pediatr Endocrinol Metab. 2019;32(1):83\u20134.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"3949_CR88","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1108\/NFS-08-2014-0077","volume":"45","author":"J Kong","year":"2015","unstructured":"Kong J, Rajikan R. Growth and nutritional status of children with maple syrup urine disease (MSUD). Nutr Food Sci. 2015;45:286\u2013301.","journal-title":"Nutr Food Sci"},{"issue":"4","key":"3949_CR89","first-page":"e24368","volume":"14","author":"KF Morton","year":"2022","unstructured":"Morton KF, Goetz RL, Linscott KB, Van Wagoner NJ. Treatment of COVID-19 in a patient with maple syrup urine disease. Cureus. 2022;14(4):e24368.","journal-title":"Cureus"},{"key":"3949_CR90","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s00431-020-03602-x","volume":"179","author":"Y Yildiz","year":"2020","unstructured":"Yildiz Y, Yildiz L, Dursun A, Tokatl\u0131 A, Co\u015fkun T, Tek\u015fam \u00d6, et al. Predictors of acute metabolic decompensation in children with maple syrup urine disease at the emergency department. Eur J Pediatrics. 2020;179:1107\u201314.","journal-title":"Eur J Pediatrics"},{"issue":"3","key":"3949_CR91","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/jimd.12337","volume":"44","author":"D O\u2019Reilly","year":"2021","unstructured":"O\u2019Reilly D, Crushell E, Hughes J, Ryan S, Rogers Y, Borovickova I, et al. Maple syrup urine disease: clinical outcomes, metabolic control, and genotypes in a screened population after four decades of newborn bloodspot screening in the Republic of Ireland. J Inherit Metab Dis. 2021;44(3):639\u201355.","journal-title":"J Inherit Metab Dis"},{"key":"3949_CR92","doi-asserted-by":"publisher","first-page":"969741","DOI":"10.3389\/fped.2022.969741","volume":"10","author":"P Sanchez-Pintos","year":"2022","unstructured":"Sanchez-Pintos P, Meavilla S, Lopez-Ramos MG, Garcia-Cazorla A, Couce ML. Intravenous branched-chain amino-acid-free solution for the treatment of metabolic decompensation episodes in Spanish pediatric patients with maple syrup urine disease. Front Pediatr. 2022;10:969741.","journal-title":"Front Pediatr"},{"issue":"6","key":"3949_CR93","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1542\/peds.68.6.856","volume":"68","author":"CL Clow","year":"1981","unstructured":"Clow CL, Reade TM, Scriver CR. Outcome of early and long-term management of classical maple syrup urine disease. Pediatrics. 1981;68(6):856\u201362.","journal-title":"Pediatrics"},{"issue":"4","key":"3949_CR94","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1651-2227.2000.tb00088.x","volume":"89","author":"U Spiekerkotter","year":"2000","unstructured":"Spiekerkotter U, Schwahn B, Korall H, Trefz FK, Andresen BS, Wendel U. Very-long-chain acyl-coenzyme A dehydrogenase (VLCAD) deficiency: monitoring of treatment by carnitine\/acylcarnitine analysis in blood spots. Acta Paediatr. 2000;89(4):492\u20135.","journal-title":"Acta Paediatr"},{"key":"3949_CR95","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s10545-017-0016-8","volume":"40","author":"S Tucci","year":"2017","unstructured":"Tucci S. Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency\u2013Studies on treatment effects and long-term outcomes in mouse models. J Inherit Metab Dis. 2017;40:317\u201323.","journal-title":"J Inherit Metab Dis"},{"key":"3949_CR96","volume-title":"GeneReviews\u00ae [Internet]","author":"ND Leslie","year":"2023","unstructured":"Leslie ND, Saenz-Ayala S. Very Long-Chain Acyl-Coenzyme A dehydrogenase deficiency. In: Adam MP, Feldman J, Mirzaa GM, editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 2023."},{"key":"3949_CR97","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ymgme.2010.05.005","volume":"101","author":"S Tucci","year":"2010","unstructured":"Tucci S, Primassin S, Ter Veld F, Spiekerkoetter U. Medium-chain triglycerides impair lipid metabolism and induce hepatic steatosis in very long-chain acyl-CoA dehydrogenase (VLCAD)-deficient mice. Mol Genet Metab. 2010;101:40\u20137.","journal-title":"Mol Genet Metab"},{"issue":"1\u20132","key":"3949_CR98","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ymgme.2015.06.006","volume":"116","author":"J Vockley","year":"2015","unstructured":"Vockley J, Marsden D, McCracken E, DeWard S, Barone A, Hsu K, et al. Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment\u2013A retrospective chart review. Mol Genet Metab. 2015;116(1\u20132):53\u201360.","journal-title":"Mol Genet Metab"},{"key":"3949_CR99","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.nmd.2021.03.015","volume":"31","author":"H Akar","year":"2021","unstructured":"Akar H, \u00c7a\u011fan M, Yildiz Y, Sivri H. Complicated peripartum course in a patient with very long-chain acyl-coenzyme A dehydrogenase (VLCAD) deficiency. Neuromuscul Disord. 2021;31:566\u20139.","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"3949_CR100","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1023\/A:1005445132327","volume":"21","author":"S Yap","year":"1998","unstructured":"Yap S, Naughten E. Homocystinuria due to cystathionine beta-synthase deficiency in ireland: 25 years\u2019 experience of a newborn screened and treated population with reference to clinical outcome and biochemical control. J Inherit Metab Dis. 1998;21(7):738\u201347.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"3949_CR101","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1542\/peds.37.3.502","volume":"37","author":"TL Perry","year":"1966","unstructured":"Perry TL, Dunn HG, Hansen S, MacDougall L, Warrington PD. Early diagnosis and treatment of homocystinuria. Pediatrics. 1966;37(3):502\u20135.","journal-title":"Pediatrics"},{"issue":"6","key":"3949_CR102","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1136\/bjo.73.6.427","volume":"73","author":"JP Burke","year":"1989","unstructured":"Burke JP, O\u2019Keefe M, Bowell R, Naughten ER. Ocular complications in homocystinuria\u2013early and late treated. Br J Ophthalmol. 1989;73(6):427\u201331.","journal-title":"Br J Ophthalmol"},{"issue":"7566","key":"3949_CR103","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S0140-6736(68)90646-6","volume":"2","author":"TL Perry","year":"1968","unstructured":"Perry TL, Hansen S, Love DL, Crawford LE, Tischler B. Treatment of homocystinuria with a low-methionine diet, supplemental cystine, and a Methyl donor. Lancet. 1968;2(7566):474\u20138.","journal-title":"Lancet"},{"issue":"9","key":"3949_CR104","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.3390\/nu15092112","volume":"15","author":"M Batycka","year":"2023","unstructured":"Batycka M, Lange E, Ehmke Vel E-SE, Jaworski M, Kobyli\u0144ska M, Lech N, et al. Relationship between bone mineral density and selected parameters of Calcium-Phosphate economy with dietary management and metabolic control in Polish pediatric patients with classical Homocystinuria-A preliminary study. Nutrients. 2023;15(9):2112.","journal-title":"Nutrients"},{"issue":"2","key":"3949_CR105","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/BF00441642","volume":"135","author":"H Grobe","year":"1980","unstructured":"Grobe H. Homocystinuria (cystathionine synthase deficiency). Results of treatment in late-diagnosed patients. Eur J Pediatr. 1980;135(2):199\u2013203.","journal-title":"Eur J Pediatr"},{"key":"3949_CR106","unstructured":"British Inherited Metabolic Diseases Group. Homocystinuria (HCU) Dietetic Management Pathway 2015 [Available from: https:\/\/www.bimdg.org.uk\/store\/enbs\/\/HCU_Dietetic_Management_Pathway_V1_April_2015_215380_12052015.pdf"},{"key":"3949_CR107","unstructured":"Metabolic Dietitians National Centre for Inherited Metabolic Disorders. Weaning your baby on a diet for HCU 2022 [Available from: https:\/\/metabolic.ie\/wp-content\/uploads\/2023\/02\/Weaning-your-baby-on-a-HCU-diet-2022.pdf"},{"issue":"1","key":"3949_CR108","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10545-016-9979-0","volume":"40","author":"AA Morris","year":"2017","unstructured":"Morris AA, Kozich V, Santra S, Andria G, Ben-Omran TI, Chakrapani AB, et al. Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency. J Inherit Metab Dis. 2017;40(1):49\u201374.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"3949_CR109","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.clnu.2017.07.013","volume":"37","author":"C Tran","year":"2018","unstructured":"Tran C, Bonafe L, Nuoffer JM, Rieger J, Berger MM. Adult classical homocystinuria requiring parenteral nutrition: pitfalls and management. Clin Nutr. 2018;37(4):1114\u201320.","journal-title":"Clin Nutr"},{"key":"3949_CR110","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cca.2016.04.002","volume":"458","author":"T Kumar","year":"2016","unstructured":"Kumar T, Sharma GS, Singh LR. Homocystinuria: therapeutic approach. Clin Chim Acta. 2016;458:55\u201362.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"3949_CR111","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ymgme.2013.10.003","volume":"110","author":"S Adam","year":"2013","unstructured":"Adam S, Almeida MF, Carbasius Weber E, Champion H, Chan H, Daly A, et al. Dietary practices in pyridoxine non-responsive homocystinuria: a European survey. Mol Genet Metab. 2013;110(4):454\u20139.","journal-title":"Mol Genet Metab"},{"key":"3949_CR112","doi-asserted-by":"crossref","unstructured":"Tummolo A, Carella R, De Giovanni D, Paterno G, Simonetti S, Tolomeo M et al. Micronutrient deficiency in inherited metabolic disorders requiring diet regimen: A brief critical review. Int J Mol Sci. 2023;24(23).","DOI":"10.3390\/ijms242317024"},{"issue":"1","key":"3949_CR113","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/ejcn.2013.218","volume":"68","author":"C Rohde","year":"2014","unstructured":"Rohde C, von Teeffelen-Heithoff A, Thiele AG, Arelin M, Mutze U, Kiener C, et al. PKU patients on a relaxed diet May be at risk for micronutrient deficiencies. Eur J Clin Nutr. 2014;68(1):119\u201324.","journal-title":"Eur J Clin Nutr"},{"issue":"Suppl 2","key":"3949_CR114","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1017\/S0007114512001523","volume":"107","author":"M Gil-Campos","year":"2012","unstructured":"Gil-Campos M, Sanjurjo Crespo P. Omega 3 fatty acids and inborn errors of metabolism. Br J Nutr. 2012;107(Suppl 2):S129\u201336.","journal-title":"Br J Nutr"},{"issue":"5","key":"3949_CR115","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jpeds.2006.12.011","volume":"150","author":"S Beblo","year":"2007","unstructured":"Beblo S, Reinhardt H, Demmelmair H, Muntau AC, Koletzko B. Effect of fish oil supplementation on fatty acid status, coordination, and fine motor skills in children with phenylketonuria. J Pediatr. 2007;150(5):479\u201384.","journal-title":"J Pediatr"},{"issue":"11","key":"3949_CR116","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1080\/21678707.2018.1536540","volume":"6","author":"A Burlina","year":"2018","unstructured":"Burlina A, Tims S, van Spronsen F, Sperl W, Burlina AP, Kuhn M, et al. The potential role of gut microbiota and its modulators in the management of propionic and methylmalonic acidemia. Expert Opin Orphan Drugs. 2018;6(11):683\u201392.","journal-title":"Expert Opin Orphan Drugs"},{"issue":"1","key":"3949_CR117","first-page":"128","volume":"26","author":"MA Vilaseca","year":"2011","unstructured":"Vilaseca MA, G\u00f3mez-L\u00f3pez L, Lambruschini N, Guti\u00e9rrez A, Garc\u00eda R, Meavilla S, et al. Long-chain polyunsaturated fatty acid concentration in patients with inborn errors of metabolism. Nutr Hosp. 2011;26(1):128\u201336.","journal-title":"Nutr Hosp"},{"issue":"4","key":"3949_CR118","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000342256","volume":"61","author":"A MaCdonald","year":"2012","unstructured":"MaCdonald A, van Rijn M, Feillet F, Lund AM, Bernstein L, Bosch AM, et al. Adherence issues in inherited metabolic disorders treated by low natural protein diets. Ann Nutr Metab. 2012;61(4):289\u201395.","journal-title":"Ann Nutr Metab"},{"issue":"6","key":"3949_CR119","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s10545-012-9455-4","volume":"35","author":"S Stockler","year":"2012","unstructured":"Stockler S, Moeslinger D, Herle M, Wimmer B, Ipsiroglu OS. Cultural aspects in the management of inborn errors of metabolism. J Inherit Metab Dis. 2012;35(6):1147\u201352.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"3949_CR120","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jada.2009.10.030","volume":"110","author":"AR Kemper","year":"2010","unstructured":"Kemper AR, Brewer CA, Singh RH. Perspectives on dietary adherence among women with inborn errors of metabolism. J Am Diet Assoc. 2010;110(2):247\u201352.","journal-title":"J Am Diet Assoc"},{"issue":"3","key":"3949_CR121","doi-asserted-by":"publisher","first-page":"108123","DOI":"10.1016\/j.ymgme.2023.108123","volume":"141","author":"K Busiah","year":"2024","unstructured":"Busiah K, Roda C, Crosnier AS, Brassier A, Servais A, Wicker C, et al. Pubertal origin of growth retardation in inborn errors of protein metabolism: A longitudinal cohort study. Mol Genet Metab. 2024;141(3):108123.","journal-title":"Mol Genet Metab"},{"issue":"02","key":"3949_CR122","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1055\/s-0041-1739288","volume":"12","author":"B Singanamalla","year":"2023","unstructured":"Singanamalla B, Paria P, Suthar R, Saini AG, Attri SV. The challenge of severe acute malnutrition in inborn errors of metabolism: does medical food alone suffice?? J Pediatr Genet. 2023;12(02):175\u20138.","journal-title":"J Pediatr Genet"},{"key":"3949_CR123","first-page":"100654","volume":"25","author":"P Rajasekar","year":"2020","unstructured":"Rajasekar P, Gannavarapu S, Napier M, Prasad AN, Vasudev A, Mantulak A, et al. Parental psychosocial aspects and stressors involved in the management of inborn errors of metabolism. Mol Genet Metab Rep. 2020;25:100654.","journal-title":"Mol Genet Metab Rep"},{"key":"3949_CR124","doi-asserted-by":"crossref","unstructured":"Schnabel-Besson E, Garbade SF, Gleich F, Grunert SC, Kramer J, Thimm E et al. Parental and child\u2019s psychosocial and financial burden living with an inherited metabolic disease identified by newborn screening. J Inherit Metab Dis. 2024.","DOI":"10.1002\/jimd.12784"},{"key":"3949_CR125","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s10897-010-9324-y","volume":"20","author":"JN Hartley","year":"2011","unstructured":"Hartley JN, Greenberg CR, Mhanni AA. Genetic counseling in a busy pediatric metabolic practice. J Genet Counsel. 2011;20:20\u20132.","journal-title":"J Genet Counsel"},{"key":"3949_CR126","volume-title":"Structuring genetic counseling sessions: initiating, contracting, ending, and referral. Facilitating the genetic counseling process","author":"P McCarthy Veach","year":"2018","unstructured":"McCarthy Veach P, LeRoy BS, Callanan NP. Structuring genetic counseling sessions: initiating, contracting, ending, and referral. Facilitating the genetic counseling process. Cham: Springer; 2018."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03949-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03949-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03949-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:03:46Z","timestamp":1763413426000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03949-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":126,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3949"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03949-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"BH, EA, HE, LA, NA, and WA received honoraria fees from Danone Nutricia as advisory board members.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"585"}}